• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胸腺癌;九项临床研究分析]

[Thymic carcinoma; analysis of nine clinical studies].

作者信息

Tamura M, Ohta Y, Ishikawa N, Tsunezuka Y, Oda M, Watanabe G

机构信息

First Department of Surgery, School of Medicine, Kanazawa University, Kanazawa, Japan.

出版信息

Kyobu Geka. 2002 Dec;55(13):1105-9.

PMID:12476558
Abstract

Nine cases of thymic carcinoma (mean age 53.9 years old, 8 males and 1 female) were treated in our hospital from 1973 to 1998. The histological subtypes of thymic carcinoma were squamous cell in six, adenosquamous cell in one, Lymphoepithelioma-like carcinoma in one, mixed type of small cell and squamous cell in one. We applied Yamakawa clinical staging, 9 cases consisted of 2 stage II cases, 2 stage III cases, and 5 stage IV b cases. Adjuvant radiotheraphy was administered in one case, registering remarkable reduction of tumor size. All of the four cases which had been performed complete resection are alive without recurrence for 17 to 136 months after operation. The mean survival time was 47 months in stage III, and 18 months in stage IV b. By the review of the Japanese literature, most of the patient who revealed long-term survival fulfill the conditions as follow, squamous cell carcinoma in histologically, earlier stage than III at his operation, performed complete resection, performed postoperative radiotherapy. Our cases covering all these condition are alive without carcinoma for 136 months after operation.

摘要

1973年至1998年期间,我院共收治9例胸腺癌患者(平均年龄53.9岁,8例男性,1例女性)。胸腺癌的组织学亚型包括鳞状细胞癌6例、腺鳞癌1例、淋巴上皮瘤样癌1例、小细胞和鳞状细胞混合型1例。我们采用山川临床分期,9例患者中包括2例II期、2例III期和5例IVb期。1例患者接受了辅助放疗,肿瘤大小显著缩小。所有4例行根治性切除的患者术后17至136个月均存活且无复发。III期患者的平均生存时间为47个月,IVb期为18个月。通过查阅日本文献,大多数长期存活的患者符合以下条件:组织学类型为鳞状细胞癌、手术时处于III期之前的早期阶段、行根治性切除、术后行放疗。我们的病例满足所有这些条件,术后136个月无癌存活。

相似文献

1
[Thymic carcinoma; analysis of nine clinical studies].[胸腺癌;九项临床研究分析]
Kyobu Geka. 2002 Dec;55(13):1105-9.
2
[Clinical study of operated nine thymic carcinomas].
Kyobu Geka. 2001 Feb;54(2):89-93; discussion 93-6.
3
[Surgical treatment of thymic carcinomas].
Kyobu Geka. 2004 Jul;57(7):555-9.
4
[Clinical study of nineteen thymic carcinomas].[19例胸腺癌的临床研究]
Nihon Kyobu Geka Gakkai Zasshi. 1996 Feb;44(2):169-74.
5
[Clinical study of six thymic carcinomas including long-term survivors].[包括长期存活者在内的六种胸腺癌的临床研究]
Kyobu Geka. 1999 May;52(5):347-54.
6
The role of radiotherapy for thymic carcinoma.放射治疗在胸腺癌中的作用。
Jpn J Clin Oncol. 2004 Dec;34(12):722-6. doi: 10.1093/jjco/hyh141.
7
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection.胸腺上皮肿瘤的新型预后分组:风险评估与治疗策略选择
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):420-7. doi: 10.1016/j.ijrobp.2007.10.006. Epub 2007 Dec 31.
8
[Long-term results of the surgical treatment for thymoma].[胸腺瘤手术治疗的长期结果]
Rinsho Kyobu Geka. 1994 Aug;14(4):309-12.
9
Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients.胸腺癌的持续积极治疗。单中心25例患者的治疗结果
Oncology. 2006;70(5):325-9. doi: 10.1159/000097944. Epub 2006 Dec 12.
10
Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis.胸腺瘤和胸腺鳞状细胞癌患者的肿瘤复发与生存情况:一项回顾性分析。
J Clin Oncol. 2004 Apr 15;22(8):1501-9. doi: 10.1200/JCO.2004.10.113.